Patent ID: 11939324
Assignee: REMYND N.V.
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 0:
1. A method of treatment of a disease comprising administering an effective amount of a compound of formula (I), or a tautomer thereof, wherein the disease is selected from the group consisting of epilepsy, neurodegenerative disorders, pain disorders, anxiety disorders, depression, bipolar disorder, psychosis, drug withdrawal, tobacco withdrawal, memory loss, dementia, schizophrenia, and panic; and wherein the compound of formula (I), or a tautomer thereof, has the structure:, wherein:
R1 is selected from the group consisting of hydrogen; F, Cl, and Br;
R2 is selected from the group consisting of hydrogen, F, Cl, and Br;
R3 is selected from the group consisting of hydrogen, F, Cl, and Br;
R4 is selected from the group consisting of hydrogen, F, Cl, and Br;
R5 is selected from the group consisting of hydrogen, F, Cl, and Br;

with the proviso that at least one of R1, R2, R3, R4 or R5 is not hydrogen;
with the proviso that said compound of formula (I) is not N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-5-[(3-fluorophenyl)methyl]isoxazole-3-carboxamide,
or a solvate, a hydrate, a salt, or a prodrug thereof.